1. Home
  2. ISTR vs CMPX Comparison

ISTR vs CMPX Comparison

Compare ISTR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$27.77

Market Cap

256.3M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.05

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
CMPX
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
256.3M
752.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ISTR
CMPX
Price
$27.77
$5.05
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$29.00
$13.44
AVG Volume (30 Days)
38.4K
1.8M
Earning Date
01-22-2026
11-05-2025
Dividend Yield
1.60%
N/A
EPS Growth
24.14
N/A
EPS
2.22
N/A
Revenue
$93,426,000.00
N/A
Revenue This Year
$7.24
N/A
Revenue Next Year
$70.19
N/A
P/E Ratio
$12.38
N/A
Revenue Growth
12.93
N/A
52 Week Low
$15.39
$1.33
52 Week High
$27.95
$5.86

Technical Indicators

Market Signals
Indicator
ISTR
CMPX
Relative Strength Index (RSI) 82.86 50.88
Support Level $27.05 $4.83
Resistance Level $27.95 $5.32
Average True Range (ATR) 0.53 0.33
MACD 0.16 -0.08
Stochastic Oscillator 96.31 20.87

Price Performance

Historical Comparison
ISTR
CMPX

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: